Skip to main content

Advertisement

Log in

Diagnosis of Invasive Fungal Infections in Children

  • Rational Diagnostics
  • Published:
Indian Pediatrics Aims and scope Submit manuscript

Abstract

Invasive fungal infections are important causes of morbidity and mortality particularly in high-risk patients. Recognizing such infections is often difficult because of non-specific symptoms and clinical signs. Timely diagnosis is also a challenge due to difficulty in obtaining adequate volume of samples, need for anaesthesia to perform certain diagnostic procedures, and insufficient data and experience related to fungal biomarkers and molecular detection tests. This results in widespread use of empiric broad spectrum antifungal agents with the consequent emergence of drug-resistant strains. This review focusses on the definition, clinical and microbial profile and diagnostic modalities for invasive fungal infections.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Rosen GP, Nielsen K, Glenn S, Abelson J, Deville J, Moore TB. Invasive fungal infections in pediatric oncology patients: 11–year experience at a single institution. J Pediatric Hematol Oncol. 2005;27:135–40.

    Article  Google Scholar 

  2. Wattier RL, Dvorak CC, Hoffman JA, Brozovich AA, Bin–Hussain I, Groll AH, et al. A prospective, international cohort study of invasive mold infections in children. J Pediatr Infect Dis Soc. 2014;4:313–22.

    Article  Google Scholar 

  3. Jordan I, Balaguer M, López–Castilla JD, Belda S, Shuffelman C, Garcia–Teresa MA, et al. for the ERICAP Study Group. Per–species risk factors and predictors of invasive Candida infections in patients admitted to pediatric intensive care units: development of ERICAP scoring systems. Pediatr Infect Dis J. 2014;33:s187–93.

    Article  Google Scholar 

  4. Jaworski R, Haponiuk I, Irga–Jaworska N, Chojnicki M, Steffens M, Paczkowski K, et al. Fungal infections in children in the early postoperative period after cardiac surgery for congenital heart disease: A single–centre experience. Interact Cardiovasc Thorac Surg. 2016;23:431–7.

    Article  PubMed  Google Scholar 

  5. De Pauw B, Walsh TJ, Donnelly JP, Stevens DA, Edwards JE, Calandra T, et al. Revised Definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) consensus group. Clin Infect Dis. 2008;46:1813–21.

    Article  PubMed  PubMed Central  Google Scholar 

  6. W Adilia, Thomas L. Progress in the Diagnosis of Invasive Fungal disease in Children. Curr Fungal Infect Rep. 2017;11:35–44.

    Article  Google Scholar 

  7. Mukherjee PK, Sheehan DJ, Hitchcock CA, Ghannoum MA. Combination treatment of invasive fungal infections. Clin Microb Rev. 2005;18:163–94.

    Article  CAS  Google Scholar 

  8. King J, Pana ZD, Lehrnbecher T, Steinbach WJ, Warris A. Recognition and clinical presentation of invasive fungal disease in neonates and children. J Pediatr Infect Dis Soc. 2017;6:S12–21.

    Article  Google Scholar 

  9. Ascioglu S, Rex JH, De Pauw B, Bennett JE, Bille J, Crokaert F, et al. Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: An international consensus. Clin Infect Dis. 2002;34:7–14.

    Article  CAS  PubMed  Google Scholar 

  10. Oz Y, Kiraz N. Diagnostic methods for fungal infections in pediatric patients: Microbiological, serological and molecular methods. Expert Rev Anti Infect Ther. 2011;9;289–98.

    Article  PubMed  Google Scholar 

  11. Badiee P, Hashemizadeh Z. Opportunistic invasive fungal infections: Diagnosis and clinical management. Indian J Med Res. 2014;139:195–204.

    PubMed  PubMed Central  Google Scholar 

  12. Clancy CJ, Nguyen MH. Finding the “missing 50%” of invasive candidiasis: How nonculture diagnostics will improve understanding of disease spectrum and transform patient care. Clin Infect Dis. 2013;56:1284–92.

    Article  PubMed  Google Scholar 

  13. Hope WW, Castagnola E, Groll AH, Roilides E, Akova M, Arendrup MC, et al. ESCMID Guideline for the Diagnosis and Management of Candida Diseases 2012: Prevention and Management of Invasive Infections in Neonates and Children Caused by Candida Spp. Clin Microbiol Infect. 2012;18:38–52.

    Article  CAS  PubMed  Google Scholar 

  14. Kontoyiannis DP, Sumoza D, Tarrand J, Bodey GP, Storey R, Raad II. Significance of aspergillemia in patients with cancer: A 10–year study. Clin Infect Dis. 2000;31:188–9.

    Article  CAS  PubMed  Google Scholar 

  15. Lass–Florl C, Resch G, Nachbaur D, Mayr A, Gastl G, Auberger J, et al. The value of computed tomographyguided percutaneous lung biopsy for diagnosis of invasive fungal infection in immunocompromised patients. Clin Infect Dis. 2007;45:e101–4.

    Article  Google Scholar 

  16. Hoenigl M, Prattes J, Spiess B, Wagner J, Prueller F, Raggam RB, et al. Performance of galactomannan, beta–dglucan, aspergillus lateral–flow device, conventional culture, and PCR tests with bronchoalveolar lavage fluid for diagnosis of invasive pulmonary aspergillosis. J Clin Microbiol. 2014;52:2039–45.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Skiada A, Lass–Floerl C, Klimko N, Ibrahim A, Roilides E, Petrikkos G. Challenges in the diagnosis and treatment of mucormycosis. Med Mycol. 2018;56:93–101.

    Article  CAS  PubMed  Google Scholar 

  18. Klont RR, Mennink–Kersten MA, Verweij PE. Utility of aspergillus antigen detection in specimens other than serum specimens. Clin Infect Dis. 2004;39:1467–74.

    Article  PubMed  Google Scholar 

  19. Leeflang MM, Debets Ossenkopp YJ, Wang J, Visser CE, Scholten RJ, Hooft L, et al. Galactomannan detection for invasive aspergillosis in immunocompromised patients. Cochrane Database of Syst Rev. 2015;4:CD007394.

    Google Scholar 

  20. Groll AH, Castagnola E, Cesaro S, Dalle JH, Engelhard D, Hope W, et al. Fourth European conference on infections in leukaemia (ECIL–4): Guidelines for diagnosis, prevention, and treatment of invasive fungal diseases in paediatric patients with cancer or allogeneic haemopoietic stem–cell transplantation. Lancet Oncol. 2014;15:e327–40.

    Article  Google Scholar 

  21. Arvanitis M, Anagnostou T, Fuchs BB, Caliendo AM, Mylonakis E. Molecular and nonmolecular diagnostic methods for invasive fungal infections. Clin Microbiol Rev. 2014;27:490–526.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Mennink–Kersten MA, Ruegebrink D, Klont RR, Warris A, Gavini F, Op den Camp HJ, et al. Bifidobacterial lipoglycan as a new cause for false–positive platelia Aspergillus enzyme–linked immunosorbent assay reactivity. J Clin Microbiol. 2005;43:3925–31.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Pana ZD, Vikelouda K, Roilides E. Diagnosis of invasive fungal diseases in pediatric patients. Expert Rev Anti Infect Ther. 2016;14:1203–13.

    Article  CAS  PubMed  Google Scholar 

  24. Thornton CR. Development of an immunochromatographic lateral–flow device for rapid serodiagnosis of invasive aspergillosis. Clin Vaccine Immunol. 2008;15:1095–105.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Pan Z, Fu M, Zhang J, Zhou H, Fu Y, Zhou J. Diagnostic accuracy of a novel lateral–flow device in invasive aspergillosis: a meta–analysis. J Med Microbiol. 2015;64:702–7.

    Article  CAS  PubMed  Google Scholar 

  26. Desmet S, Van Wijngaerden E, Maertens J, Verhaegen J, Verbeken E, De Munter P, et al. Serum (1–3)–beta–Dglucan as a tool for diagnosis of Pneumocystis jirovecii pneumonia in patients with human immunodeficiency virus infection or hematological malignancy. J Clin Microbiol. 2009;47:3871–4.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Mennink–Kersten MA, Ruegebrink D, Verweij PE. Pseudomonas aeruginosa as a cause of 1,3–beta–D–glucan assay reactivity. Clin Infect Dis. 2008;46:1930–1.

    Article  PubMed  Google Scholar 

  28. Marty FM, Lowry CM, Lempitski SJ, Kubiak DW, Finkelman MA, Baden LR. Reactivity of (1–>3)–beta–dglucan assay with commonly used intravenous antimicrobials. Antimicrob Agents Chemother. 2006;50:3450–3.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Usami M, Ohata A, Horiuchi T, Nagasawa K, Wakabayashi T, Tanaka S. Positive (1–>3)–beta–D–glucan in blood components and release of (1–>3)–beta–D–glucan from depth–type membrane filters for blood processing. Transfus. 2002;42:1189–95.

    Article  CAS  Google Scholar 

  30. Smith PB, Benjamin DK, Jr., Alexander BD, Johnson MD, Finkelman MA, Steinbach WJ. Quantification of 1,3–beta–D–glucan levels in children: preliminary data for diagnostic use of the beta–glucan assay in a pediatric setting. Clin Vaccine Immunol. 2007;14:924–5.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. Kumar J, Singh A, Seth R, Xess I, Jana M, Kabra SK. Prevalence and predictors of invasive fungal infections in children with persistent febrile neutropenia treated for acute leukemia–A prospective study. Indian J Pediatr. 2018;85:1090–5.

    Article  PubMed  Google Scholar 

  32. Mikulska M, Calandra T, Sanguinetti M, Poulain D, Viscoli C. The use of mannan antigen and anti–mannan antibodies in the diagnosis of invasive candidiasis: recommendations from the third European conference on infections in leukemia. Crit Care. 2010;14:R222.

    Article  PubMed  PubMed Central  Google Scholar 

  33. Vidal JE, Boulware DR. Lateral flow assay for cryptococcal antigen: An important advance to improve the continuum of HIV care and reduce cryptococcal meningitisrelated mortality. Rev Inst Med Trop Sao Paulo. 2015;57:38–45.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  34. Azar MM, Hage CA. Laboratory diagnostics for histoplasmosis. J Clin Microbiol. 2017;55:1612–20.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  35. Warhurst G, Maddi S, Dunn G, Ghrew M, Chadwick P, Alexander P, et al. Diagnostic accuracy of SeptiFast multipathogen real–time PCR in the setting of suspected healthcare–associated bloodstream infection. Intensive Care Med. 2015;41:86–93.

    Article  CAS  PubMed  Google Scholar 

  36. Chong GL, van de Sande WW, Dingemans GJ, Gaajetaan GR, Vonk AG, Hayette MP, et al. Validation of a new Aspergillus real–time PCR assay for direct detection of Aspergillus and azole resistance of Aspergillus fumigatus on bronchoalveolar lavage fluid. J Clin Microbiol. 2015;53:868–74.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  37. Ashdown BC, Tien RD, Felsberg GJ. Aspergillosis of the brain and paranasal sinuses in immunocompromised patients: CT and MR imaging findings. Am J Roentgenol. 1994;162:155–9.

    Article  CAS  Google Scholar 

  38. Georgiadou SP, Sipsas NV, Marom EM, Kontoyiannis DP. The diagnostic value of halo and reversed halo signs for invasive mold infections in compromised hosts. Clin Infect Dis. 2011;52:1144–55.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Rachna Seth.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Seth, R., Xess, I. & Jana, M. Diagnosis of Invasive Fungal Infections in Children. Indian Pediatr 56, 229–236 (2019). https://doi.org/10.1007/s13312-019-1505-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13312-019-1505-7

Keywords

Navigation